• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

They were terrorist then and now

Doc Who

Active Member
2021-01-07T065619Z_780004832_RC2U2L9P24HR_RTRMADP_3_USA-ELECTION-CAPITOL-SECURITY-1.jpg